These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 859104)

  • 21. Modification of avoidance behavior in 6-hydroxydopamine-treated rats by stimulation of central noradrenergic and dopaminergic receptors.
    Lenard LG; Beer B
    Pharmacol Biochem Behav; 1975; 3(5):887-93. PubMed ID: 1208631
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depletion of catecholamines in the brain of rats differentially affects stimulation of locomotor activity by caffeine, D-amphetamine, and methylphenidate.
    Finn IB; Iuvone PM; Holtzman SG
    Neuropharmacology; 1990 Jul; 29(7):625-31. PubMed ID: 1974712
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of dopaminergic agonists and antagonists on in vivo cyclic nucleotide content: relation of guanosine 3':5'- monophosphate (cGMP) changes in cerebellum to behavior.
    Breese GR; Mueller RA; Mailman RB
    J Pharmacol Exp Ther; 1979 May; 209(2):262-70. PubMed ID: 35602
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of apomorphine on serotonin neurons in dorsal raphe nucleus and catecholamine nerve terminals in paraventricular hypothalamic nucleus. Histofluorescence studies.
    Smialowska M
    Pol J Pharmacol Pharm; 1975; 27(4):419-28. PubMed ID: 126447
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chronic effects of nicotine on mesolimbic dopaminergic system in rats.
    Fung YK; Lau YS
    Pharmacol Biochem Behav; 1992 Jan; 41(1):57-63. PubMed ID: 1347177
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of dopaminergic system activation on feeding behavior and growth performance of the sea bass (Dicentrarchus labrax): a self-feeding approach.
    Leal E; Fernández-Durán B; Agulleiro MJ; Conde-Siera M; Míguez JM; Cerdá-Reverter JM
    Horm Behav; 2013 Jun; 64(1):113-21. PubMed ID: 23747830
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A new and highly sensitive method for measuring 3-methoxytyramine using HPLC with electrochemical detection. Studies with drugs which alter dopamine metabolism in the brain.
    Heal DJ; Frankland AT; Buckett WR
    Neuropharmacology; 1990 Dec; 29(12):1141-50. PubMed ID: 2293058
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differentiation of dopamine agonists using drug-induced rotation in rats with unilateral or bilateral 6-hydroxydopamine destruction of ascending dopamine pathways.
    Reavill C; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Mar; 32(5):865-70. PubMed ID: 6301501
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Significance of dopamine metabolites in the evaluation of drugs acting on dopaminergic neurons.
    Di Giulio AM; Groppetti A; Cattabeni F; Galli CL; Maggi A; Algeri S; Ponzio F
    Eur J Pharmacol; 1978 Nov; 52(2):201-7. PubMed ID: 729633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic variations in midbrain dopamine cell number: parallel with differences in responses to dopaminergic agonists and in naturalistic behaviors mediated by central dopaminergic systems.
    Fink JS; Reis DJ
    Brain Res; 1981 Oct; 222(2):335-49. PubMed ID: 6116521
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the mechanism of amphetamine-induced behavioural changes in the mouse. III. Effects of apomorphine and Fla 63.
    Thomas KV; Handley SL
    Arzneimittelforschung; 1978; 28(6):993-7. PubMed ID: 582011
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of haloperidol and d-amphetamine on in vivo 3H-spiroperiodol binding in the rat forebrain(1).
    Saelens JK; Simke JP; Neale SE; Weeks BJ; Selwyn M
    Arch Int Pharmacodyn Ther; 1980 Jul; 246(1):98-107. PubMed ID: 7447553
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Methylphenidate-like effects of the new antidepressant drug nomifensine (HOE 984).
    Braestrup C; Scheel-Krüger J
    Eur J Pharmacol; 1976 Aug; 38(2):305-12. PubMed ID: 986308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. On certain effects of dopaminergic agents in pentylenetetrazol convulsions.
    Lazarova MB; Roussinov KS
    Acta Physiol Pharmacol Bulg; 1978; 4(3):50-5. PubMed ID: 751452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Circling behavior following systemic d-amphetamine administration: potential noradrenergic and dopaminergic involvement.
    Kokkinidis L; Anisman H
    Psychopharmacology (Berl); 1979 Jun; 64(1):45-54. PubMed ID: 113831
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of dopaminergic and noradrenergic mechanisms in Metrazole convulsions in mice.
    Dadkar VN; Dahanukar SA; Sheth UK
    Indian J Med Res; 1979 Sep; 70():492-4. PubMed ID: 535961
    [No Abstract]   [Full Text] [Related]  

  • 37. Effects of amphetamine, methylphenidate, and apomorphine on regional brain serotonin and 5-hydroxyindole acetic acid.
    Kuczenski R; Segal DS; Leith NJ; Applegate CD
    Psychopharmacology (Berl); 1987; 93(3):329-35. PubMed ID: 2448842
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Influence of dopaminergic agonists and antagonists on serum prolactin concentrations in the rat.
    Horowski R; Gräf HJ
    Neuroendocrinology; 1976; 22(3):273-86. PubMed ID: 1028957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Food intake of rats depleted of dopamine as neonates is impaired by inhibition of catecholamine biosynthesis.
    Potter BM; Bruno JP
    Neurosci Lett; 1989 Dec; 107(1-3):295-300. PubMed ID: 2515502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of central dopamine depletion on the d-amphetamine discriminative stimulus in rats.
    Woolverton WL; Cervo L
    Psychopharmacology (Berl); 1986; 88(2):196-200. PubMed ID: 3006111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.